Labeling of bupivacaine solutions
Baumgarten, R.K.
Regional Anesthesia 17(4): 240-242
1992
ISSN/ISBN: 0146-521X PMID: 1515395 Document Number: 393541
Document emailed within 1 workday
Related Documents
Concepcion, M.A.; Lambert, D.H.; Welch, K.A.; Covino, B.G. 1988: Tourniquet pain during spinal anesthesia: a comparison of plain solutions of tetracaine and bupivacaine Anesthesia and Analgesia 67(9): 828-832Sattler, A.; Jage, J.; Krämer, I. 1998: Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine Die Pharmazie 53(6): 386-391
Sánchez-Pereles, M.C.; Uribarri, F.J.; Gragera, I. 1993: 0.0625% bupivacaine compared with 0.125% bupivacaine continuously perfused epidurally during vaginal delivery Revista Espanola de Anestesiologia y Reanimacion 40(1): 9-11
Weindler, M.; Kossmann, B.; Dick, W.; Mehrkens, H.H.; Seeling, W.; Schwabe, K. 1984: Catheter peridural anesthesia with bupivacaine HCI and bupivacaine CO2. A comparison and the effects of premedication Regional-Anaesthesie 7(4): 125-130
Boutonnat, J.; Barbier, M.; Ronot, X.; Seigneurin, D. 2000: Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells? Morphologie: Bulletin de l'Association des Anatomistes 84(265): 11-15
Mazoit, J.X.; Boïco, O.; Samii, K. 1993: Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart Anesthesia and Analgesia 77(3): 477-482
Jörgensen, H. 1978: Epidural anesthesia with bupivacaine 0.75% in comparison with bupivacaine 0.5% and mepivacaine 1.5% with adrenaline Der Anaesthesist 27(1): Spec Sect: 11-15
Snoeck, M.M.J.; Vree, T.B.; Gielen, M.J.M.; Lagerwert, A.J. 2003: Steady state bupivacaine plasma concentrations and safety of a femoral "3-in-1" nerve block with bupivacaine in patients over 80 years of age International Journal of Clinical Pharmacology and Therapeutics 41(3): 107-113
Gao, F.; Waters, B.; Seager, J.; Dowling, C.; Vickers, M.D. 1995: Comparison of bupivacaine plus buprenorphine with bupivacaine alone by caudal blockade for post-operative pain relief after hip and knee arthroplasty European Journal of Anaesthesiology 12(5): 471-476
Valairucha, S.; Maboonvanon, P.; Napachoti, T.; Sirivanasandha, B.; Suraseranuvongse, S. 2005: Cost-effectiveness of thoracic patient-controlled epidural analgesia using bupivacaine with fentanyl vs bupivacaine with morphine after thoracotomy and upper abdominal surgery Journal of the Medical Association of Thailand 88(7): 921-927
Niyogi, S.; Santra, S.; Chakraborty, J.; Chakraborty, S.; Mandal, S.; Mondal, C.R. 2011: A comparative study of duration of postoperative analgesia between epidural bupivacaine and epidural clonidine plus bupivacaine in lumbar laminectomy surgery under general anaesthesia Journal of the Indian Medical Association 109(4): 230-233
Pongraweewan, O.; Inchua, N.; Kitsiripant, C.; Kongmuang, B.; Tiwirach, W. 2016: Onset time of 2% Lidocaine and 0.5% Bupivacaine Mixture versus 0.5% Bupivacaine Alone using Ultrasound and Double Nerve Stimulation for Infraclavicular Brachial Plexus Anesthesia in ESRD Patients Undergoing Arteriovenous Fistula Creation Journal of the Medical Association of Thailand 99(5): 589-595
2014: Food labeling; nutrition labeling of standard menu items in restaurants and similar retail food establishments. Final rule Federal Register 79(230): 71155-71259
Haque, M.M.; Aleem, M.A.; Haque, F.H.; Siddique, A.B.; Afrose, R. 2018: Efficacy of 0.5% Hyperbaric Bupivacaine with Dexamethasone versus 0.5% Hyperbaric Bupivacaine alone in Spinal Anaesthesia for Patient Undergoing Lower Abdominal Urological and Lower Limb Orthopedic Surgeries Mymensingh Medical Journal: Mmj 27(2): 375-381
Apley, M.D. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots Journal of the American Veterinary Medical Association 207(7): 901
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Brodin, A.; Nyqvist-Mayer, A. 1982: In vitro release studies on lidocaine aqueous solutions, micellar solutions, and o/w emulsions Acta Pharmaceutica Suecica 19(4): 267-284
Viola, A. 2008: Solutions to the HIM work force shortage. As federal legislation stalls, a community seeks local solutions Journal of Ahima 79(9): 18 20
Montanari, L.; Pavanetto, F.; Ponci, R. 1983: Foreign particle contamination in high volume injectable solutions and in powders for injectable solutions. Proposals for an Italian standard Il Farmaco; Edizione Pratica 37(12): 397-407
Bancher, E.; Washüttl, J.; Riederer, P. 1972: Effect of - 60 Co-irradiation on -carotene solutions. I. Qualitative and quantitative studies of the irradiation of petroleum ether and n-heptane solutions International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 42(3): 355-361